We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,357
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
GameStop
GME
$8.63B
| $1.74M | ﹤0.01% |
1,143,136
-94,300
| -8% | -$138K |
|
|
CBB
1852
DELISTED
Cincinnati Bell Inc.
CBB
| $1.74M | ﹤0.01% |
165,873
+8,011
| +5% | +$49.2K |
|
|
HIBB
1853
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $1.73M | ﹤0.01% |
61,591
+2,108
| +4% | +$53.5K |
|
1854
Conduent
CNDT
$271M
| $1.73M | ﹤0.01% |
278,261
+4,229
| +2% | +$26.5K |
|
|
TERP
1855
DELISTED
TerraForm Power, Inc
TERP
| $1.72M | ﹤0.01% |
111,976
+7,470
| +7% | +$120K |
|
1856
Digi International
DGII
$3.13B
| $1.72M | ﹤0.01% |
96,761
+4,826
| +5% | +$76.6K |
|
1857
AtriCure
ATRC
$2.01B
| $1.71M | ﹤0.01% |
52,493
+1,217
| +2% | +$34.6K |
|
1858
Stratasys
SSYS
$760M
| $1.7M | ﹤0.01% |
83,936
+1,129
| +1% | +$22.5K |
|
1859
World Acceptance Corp
WRLD
$886M
| $1.7M | ﹤0.01% |
19,627
-433
| -2% | -$44.6K |
|
1860
Hamilton Lane
HLNE
$5.43B
| $1.69M | ﹤0.01% |
28,372
+1,521
| +6% | +$87.8K |
|
1861
OraSure Technologies
OSUR
$275M
| $1.69M | ﹤0.01% |
210,520
+10,753
| +5% | +$86.9K |
|
1862
Blackstone
BX
$107B
| $1.68M | ﹤0.01% |
30,112
+326
| +1% | +$16.9K |
|
|
JAG
1863
DELISTED
Jagged Peak Energy Inc.
JAG
| $1.68M | ﹤0.01% |
197,660
+11,527
| +6% | +$84.2K |
|
1864
MYR Group
MYRG
$5.16B
| $1.67M | ﹤0.01% |
51,356
+2,397
| +5% | +$79.1K |
|
|
PENG
1865
Penguin Solutions Inc
PENG
$2.88B
| $1.66M | ﹤0.01% |
87,694
+5,986
| +7% | +$92.7K |
|
|
ECHO
1866
EchoStar
ECHO
$25.3B
| $1.66M | ﹤0.01% |
38,406
+531
| +1% | +$21.3K |
|
|
KREF
1867
KKR Real Estate Finance Trust
KREF
$478M
| $1.66M | ﹤0.01% |
81,384
+41,078
| +102% | +$821K |
|
1868
Fate Therapeutics
FATE
$290M
| $1.66M | ﹤0.01% |
84,690
+6,875
| +9% | +$109K |
|
|
DRNA
1869
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.65M | ﹤0.01% |
74,804
+2,114
| +3% | +$42.5K |
|
1870
Douglas Dynamics
PLOW
$1.04B
| $1.65M | ﹤0.01% |
29,948
+383
| +1% | +$19.3K |
|
1871
Adtran
ADTN
$611M
| $1.64M | ﹤0.01% |
165,536
+6,383
| +4% | +$60.8K |
|
1872
Phibro Animal Health
PAHC
$1.44B
| $1.64M | ﹤0.01% |
65,931
+2,838
| +4% | +$65.9K |
|
|
DCPH
1873
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.63M | ﹤0.01% |
26,232
+3,739
| +17% | +$178K |
|
1874
REX American Resources
REX
$1.43B
| $1.62M | ﹤0.01% |
118,914
+6,006
| +5% | +$83.1K |
|
1875
Appian
APPN
$2.23B
| $1.62M | ﹤0.01% |
42,453
+3,946
| +10% | +$170K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.